Literature DB >> 27518640

Blood transfusion and haemostatic management in the perioperative period.

A J McIntyre1.   

Abstract

A lower transfusion trigger, a better understanding of haemostasis, and an awareness of alternatives to homologous transfusion should make the practice of transfusion medicine more rational.RéSUMé: Un seuil d'hémoglobine plus bas en prétransfusion, une meilleure compréhension de l'hémostase et la connaissance d'alternatives à la transfusion homologue devraient rendre la pratique de la transfusion sanguine plus rationnelle.

Entities:  

Year:  1992        PMID: 27518640     DOI: 10.1007/BF03008848

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  34 in total

Review 1.  Intraoperative blood salvage.

Authors:  A A Pineda; M Valbonesi
Journal:  Baillieres Clin Haematol       Date:  1990-04

2.  Hypotension during transfusion of autologous blood.

Authors:  A C Miller; L Scherba-Krugliak; P T Toy; K Drasner
Journal:  Anesthesiology       Date:  1991-03       Impact factor: 7.892

Review 3.  Indications for the use of cytomegalovirus-seronegative blood products.

Authors:  J K Preiksaitis
Journal:  Transfus Med Rev       Date:  1991-01

Review 4.  Blood transfusion support in liver transplantation.

Authors:  J Nusbacher
Journal:  Transfus Med Rev       Date:  1991-07

Review 5.  Irradiation of blood products. Indications and guidelines.

Authors:  S F Leitman; P V Holland
Journal:  Transfusion       Date:  1985 Jul-Aug       Impact factor: 3.157

Review 6.  Current risk of transfusion-associated human immunodeficiency virus infection.

Authors:  J E Menitove
Journal:  Arch Pathol Lab Med       Date:  1990-03       Impact factor: 5.534

7.  Prophylactic tranexamic acid decreases bleeding after cardiac operations.

Authors:  J C Horrow; J Hlavacek; M D Strong; W Collier; I Brodsky; S M Goldman; I P Goel
Journal:  J Thorac Cardiovasc Surg       Date:  1990-01       Impact factor: 5.209

8.  Preoperative hemostatic evaluation: which tests, if any?

Authors:  S I Rapaport
Journal:  Blood       Date:  1983-02       Impact factor: 22.113

9.  Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.

Authors:  L T Goodnough; S Rudnick; T H Price; S K Ballas; M L Collins; J P Crowley; M Kosmin; M S Kruskall; B A Lenes; J E Menitove
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

10.  Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization.

Authors:  W Dietrich; M Spannagl; M Jochum; P Wendt; W Schramm; A Barankay; F Sebening; J A Richter
Journal:  Anesthesiology       Date:  1990-12       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.